Selected Announcement | China Power's electricity sales in the first eight months increased by more than 30% year-on-year; Sino Biopharm: The Alzheimer's disease patch has been approved for market launch.

cls.cn · Sep 26 07:54

港股重要公告如下：

1）公司要闻

$中国电力 (02380.HK)$：前8月合并总售电量为8777.36万兆瓦时，同比增加31.24%。其中8月的合并总售电量为1118.64万兆瓦时，同比增加22.30%。

$玖龙纸业 (02689.HK)$：发布截至6月30日止年度业绩，期内收入594.96亿元，同比增加4.86%；净利润7.51亿元，同比扭亏为盈。

$新创建集团 (00659.HK)$：发布截至2024年6月30日止年度业绩，净利润20.84亿港元，同比增加44.05%。

$深圳高速公路股份 (00548.HK)$：8月，梅观高速、机荷东段、机荷西段、沿江项目及外环项目路费收入分别为人民币1451.7万元、6137.1万元、5173.8万元、7045.6万元及1.07亿元，同比分别增加4.76%、减少1.61%、增加2.96%、增长23.26%及减少6.14%。

$中国生物制药 (01177.HK)$ ：“利斯的明透皮贴剂”获批上市，用于治疗轻、中度阿尔茨海默病的症状。这是首个获批上市的国产利斯的明透皮贴剂。

$中国恒大 (03333.HK)$ ：中国证监会发布行政处罚决定书，对时任恒大总裁夏海钧采取终身证券市场禁入措施，罚没1500万。

$中国旭阳集团 (01907.HK)$：与航天101所签订有关液氢的三方战略合作框架协议。

$富力地产 (02777.HK)$：高等法院颁令将对兆晞等附属公司呈请聆讯延期至2025年3月5日。

$信利国际 (00732.HK)$：终止AMOLED合资协议。

$重庆农村商业银行 (03618.HK)$：同意对浙江网商银行同业授信额度12亿元。

2）回购动态

$华润燃气 (01193.HK)$：拟根据授权于公开市场购回至少4579.74万股。

$腾讯控股 (00700.HK)$：斥资7.01亿港元回购173万股，回购价401.40-408.80港元。

$美团-W (03690.HK)$：斥资约4.1亿港元回购291.9万股，回购价139.7-140.8港元。

$名创优品 (09896.HK)$：斥资1970.92万港元回购75万股，回购价25.15-27.2港元。

$药明康德 (02359.HK)$：斥资2.525亿元人民币回购582.89万股A股。

$药明生物 (02269.HK)$9月25日斥资1725.79万港元回购132.55万股

$新秀丽 (01910.HK)$9月25日斥资2057.88万港元回购112.35万股

编辑/new

Important announcements in Hong Kong stocks are as follows:

1) Company News

$CHINA POWER (02380.HK)$The total consolidated electricity sales volume for the first 8 months was 87.7736 million megawatt-hours, an increase of 31.24% year-on-year. Among them, the total consolidated electricity sales volume in August was 11.1864 million megawatt-hours, an increase of 22.30% year-on-year.

$ND PAPER (02689.HK)$Reported annual performance as of June 30, with revenue of 59.496 billion yuan, a 4.86% year-on-year increase; net income of 0.751 billion yuan, turning losses into profits year-on-year.

$NWS HOLDINGS (00659.HK)$Reported annual performance as of June 30, 2024, with a net income of 2.084 billion Hong Kong dollars, an increase of 44.05% year-on-year.

$SHENZHENEXPRESS (00548.HK)$In August, the toll revenue of Mei Guan Expressway, Jiheda East Section, Jiheda West Section, Along the River Project, and Outer Ring Project were RMB 14.517 million, 61.371 million yuan, 51.738 million yuan, 70.456 million yuan, and 0.107 billion yuan respectively, with year-on-year increases of 4.76%, decrease of 1.61%, increase of 2.96%, growth of 23.26%, and decrease of 6.14%.

$SINO BIOPHARM (01177.HK)$ "LIS's Ming Transdermal Patch" has been approved for market launch, used to treat symptoms of mild to moderate Alzheimer's disease. This is the first domestically approved LIS Ming transdermal patch to be launched.

$EVERGRANDE (03333.HK)$ China Securities Regulatory Commission issued an administrative penalty decision, taking lifelong securities market entry ban measures against the then president of Evergrande, Xia Haijun, and imposing a fine of 15 million.

$CHINA RISUN GP (01907.HK)$Signed a trilateral strategic cooperation framework agreement with Aerospace 101 on liquid hydrogen.

$R&F PROPERTIES (02777.HK)$The High Court has ordered the hearing for subsidiaries of Zhaoxi Group to be postponed until March 5, 2025.

$TRULY INT'L (00732.HK)$Termination of the AMOLED joint venture agreement.

$CQRC BANK (03618.HK)$Agreed to a RMB 1.2 billion interbank credit line for Zhejiang Net Business Bank.

2) Repurchase Dynamics

$CHINA RES GAS (01193.HK)$Intends to repurchase at least 45.7974 million shares on the open market.

$TENCENT (00700.HK)$Investing 0.701 billion Hong Kong dollars to repurchase 1.73 million shares, with repurchase price of 401.40-408.80 Hong Kong dollars.

$MEITUAN-W (03690.HK)$Investing approximately 0.41 billion Hong Kong dollars to repurchase 2.919 million shares, with repurchase price of 139.7-140.8 Hong Kong dollars.

$MNSO (09896.HK)$Investing 19.7092 million Hong Kong dollars to repurchase 0.75 million shares, with repurchase price of 25.15-27.2 Hong Kong dollars.

$WUXI APPTEC (02359.HK)$Invested 0.2525 billion yuan to repurchase 5.8289 million A shares.

$WUXI BIO (02269.HK)$Invested 17.2579 million Hong Kong dollars to repurchase 1.3255 million shares on September 25th.

$SAMSONITE (01910.HK)$Invested 20.5788 million Hong Kong dollars to repurchase 1.1235 million shares on September 25th.

Editor/new

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

公告精选 | 中国电力前8月售电量同比增逾三成；中国生物制药：治疗阿尔茨海默病贴剂获批上市

Selected Announcement | China Power's electricity sales in the first eight months increased by more than 30% year-on-year; Sino Biopharm: The Alzheimer's disease patch has been approved for market launch.

Risk Disclaimer

Statement